DEA pseudoephedrine rule ups reporting threshold; Hatch pushes methamphetamine bill.
This article was originally published in The Tan Sheet
Executive Summary
SEN. HATCH AIMING FOR FLOOR CONSIDERATION OF METHAMPHETAMINE BILL in early September when Congress returns from its August recess. Sen. Orrin Hatch (R-Utah) still plans to "hotline" S 1965 through the Senate by unanimous consent despite publication of the Drug Enforcement Administration's final pseudoephedrine regs on Aug. 7. The bill attempts to restrain illicit production of methamphetamine by imposing, among other things, new controls on the sale of precursor substances such as pseudoephedrine and phenylpropanolamine ("The Tan Sheet" July 22, p. 3).
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning